Phosphorylated Tau 181 (pTau-181)

What this laboratory test evaluates

DetailsThis test measures the concentration of p-Tau181 protein in the blood. Elevated levels of p-Tau181 are associated with tauopathies, including Alzheimer's disease, and can be used to differentiate Alzheimer's from other neurodegenerative conditions. This biomarker is particularly valuable for early diagnosis, monitoring disease progression, and evaluating response to therapeutic interventions in Alzheimer's disease and related disorders.

What type of sample is required for this test?Plasma

Test ResourcesFor more information, please consult your healthcare provider.

Additional test information

This test measures the concentration of p-Tau181 protein in the blood. Elevated levels of p-Tau181 are associated with tauopathies, including Alzheimer's disease, and can be used to differentiate Alzheimer's from other neurodegenerative conditions. This biomarker is particularly valuable for early diagnosis, monitoring disease progression, and evaluating response to therapeutic interventions in Alzheimer's disease and related disorders.

Collection and processing

• Sample type: Plasma
• Fasting: No
• Estimated laboratory processing: Results should arrive 1 – 3 business days after the lab receives samples.

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.

Related Sunridge care

Learn how Sunridge approaches Neurologic Conditions and ask whether this test is appropriate for your clinical question.